English Spanish Chinese Russian French Japanese Portuguese Hindi Telugu Tamil

Gesundheitswissenschaftliches Journal

  • ISSN: 1108-7366
  • H-Index der Zeitschrift: 51
  • Zitierbewertung der Zeitschrift: 10.69
  • Journal-Impact-Faktor: 9.13
Indiziert in
  • Genamics JournalSeek
  • Nationale Wissensinfrastruktur Chinas (CNKI)
  • CiteFactor
  • CINAHL Komplett
  • Scimago
  • Elektronische Zeitschriftenbibliothek
  • Verzeichnis der Indexierung von Forschungszeitschriften (DRJI)
  • EMCare
  • OCLC – WorldCat
  • Kommission für Universitätsstipendien
  • Genfer Stiftung für medizinische Ausbildung und Forschung
  • Euro-Pub
  • Google Scholar
  • SHERPA ROMEO
  • Geheime Suchmaschinenlabore
Mehr sehen
Teile diese Seite

Abstrakt

A Real-Life Approach for Evaluation of Rapid Ag Testing in Sars-Cov2 Infection

Michel Prost and Lara Spiral SA

Objective: The aim of this work was to explore reliability and performance of 4 Ag rapid test device on random clinical specimens routinely collected for SARS-CoV2 diagnosis.

Methods: Run 4 kinds of Ag rapid test devices according to manufacturer’s instructions with negative and positive VTM nasopharyngeal specimens which were preprocessed in a same way.

Results: 47 negative specimens for SARS-CoV2 confirmed by RT-PCR were tested. All the devices showed correct SARS-CoV2 negative results with negative specimens (29 PCR negative for SARS-CoV2 without any request for other diagnosis and 18 PCR negative for SARS-CoV2 but positive for at least one respiratory virus by Panther Fusion®).

86 positive specimens for SARS-CoV2 confirmed by RT-PCR were tested. All the devices showed correct SARS-CoV2 positive results in 60/86 positive specimens. All the devices showed SARS-CoV2 negative results in 16/86 positive specimens. In the remaining 10 specimens testing, 4 devices gave different results.

Conclusion: Rapid Ag test devices are alternative for SARS-CoV2 diagnosis when lacking time or laboratory environment. Nasopharyngeal specimens should be positive by rapid Ag testing if viral burden correspond to Ct of around 30 or less by RT-PCR. At least for devices targeting N Ag, molecular variations within S gene do not influence performance of the test, which is the case for AllTest and Acro Biotech.